Flash Finance

Astec LifeSciences LimitedASTECCorporate

Pesticides / Agrochemicals - Indian Latest results: Jun 2026 14 quarters of data
Consolidated Standalone
₹710.45
MCap ₹1,583 Cr
Astec LifeSciences Limited — Stock analysis & AI research Astec LifeSciences Limited — Seasonality — best & worst months Astec LifeSciences Limited — Technical indicators & charts Astec LifeSciences Limited — Technical setup — score, trend, support & resistance Astec LifeSciences Limited — Live exchange announcements
📋 Promoters Increasing Stake 📈 Strong Trend Stocks (ADX > 25)📈 Bollinger Squeeze Stocks📈 Multi-Timeframe Bullish Stocks 🏭 Chemicals sector
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹84 Cr
Sales · Jun 2026
-8.3% YoY
₹-1 Cr
Operating Profit · Jun 2026
+93.9% YoY
-0.8%
OPM % · Jun 2026
+93.4% YoY
₹-19 Cr
Net Profit · Jun 2026
+43.4% YoY
₹-8.40
EPS · Jun 2026
+50.1% YoY

📝 Astec LifeSciences Limited — results explained

Quarter ended June 2026 (Q1 FY27)

Astec LifeSciences Limited reported revenue of ₹84 crore for the quarter ended June 2026 (Q1 FY27), down 8.3% from ₹91 crore in the same quarter last year, and down 47.3% sequentially over the March 2026 quarter.

The company reported a net loss of ₹19 crore, against a net loss of ₹33 crore in the same quarter last year. Earnings per share (EPS) came in at ₹-8.40.

Operating profit stood at ₹-1 crore — an operating margin (OPM) of -0.8%, compared with -12.1% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Astec LifeSciences Limited posted revenue of ₹448 crore, a growth of 17.5% over FY25, with a net loss of ₹81 crore.

On a trailing-twelve-month (TTM) basis, revenue stands at ₹441 crore with a net loss of ₹67 crore.

Valuation snapshot

At the current price of ₹710.45, ASTEC has a market capitalisation of ₹1,583 crore.

Within the Pesticides / Agrochemicals - Indian industry, it is the 9th-largest of the 19 companies we track by market value.

Shareholding pattern

As of Jun 2026, promoters held 71.96%, foreign institutional investors (FIIs) 0.01%, domestic institutional investors (DIIs) 3.33%, public shareholders 24.69% of Astec LifeSciences Limited.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹1,583 Cr
Current Price ?
₹710.5
P/E ?
N/A
Industry P/E ?
17.40
P/B ?
4.06
P/S ?
3.59
P/FCF ?
-18.41
Enterprise Value ?
₹2,032 Cr
EV/EBITDA ?
350.20
PEG ?
N/A
Earnings Yield ?
-1.9%
Dividend Yield ?
0.00%
Profitability & Returns
Sales (TTM) ?
₹441 Cr
OPM ?
1.3%
Profit after tax (TTM) ?
₹-67 Cr
EPS (TTM) ?
₹-29.89
ROCE ?
-5.0%
ROE ?
-17.1%
ROA ?
-7.1%
Growth
Sales — latest qtr ?
₹84 Cr
PAT — latest qtr ?
₹-19 Cr
YoY qtr sales growth ?
-8.3%
YoY qtr profit growth ?
43.4%
Sales growth (3y) ?
-11%
Sales growth (5y) ?
-4%
Profit growth (3y) ?
N/A
Profit growth (5y) ?
N/A
Financial Health
Debt ?
₹449 Cr
Debt to Equity ?
1.15
Interest Coverage ?
-1.4
Current Ratio ?
N/A
Ownership
Promoter holding ?
71.96%
Change in promoter holding ?
1.09%
Pledged percentage ?
N/A
Market
Return 3 months ?
2.9%
Return 6 months ?
-2.2%

🗓️ Quarterly results (14 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best
Metric Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 YoY % QoQ %
Sales 12714311151154699994120917412515984 -8.3% -47.3%
Operating Profit 53-3-1813-46-20-66-11-749-1 +93.9% -107.3%
Other Income 32112122111131 +43.6% -72.1%
Interest 66667791010118788 -30.0% -2.5%
Depreciation 8999991111121110111211 -3.7% -6.1%
Profit Before Tax -6-11-18-32-1-62-39-25-16-33-24-16-8-19 +43.2% -136.0%
Net Profit -5-8-13-24-1-40-39-40-16-33-24-16-8-19 +43.4% -140.5%
EPS -2.22-4.18-6.00-12.41-0.43-20.26-17.21-20.59-7.18-16.85-10.96-7.04-3.49-8.40 +50.1% -140.7%
OPM % 4.3% 2.2% -3.1% -36.1% 8.3% -66.7% -20.0% -6.1% 4.6% -12.1% -9.1% 3.2% 5.8% -0.8% +93.4% -113.8%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric FY25 FY26 TTM YoY %
Sales ₹381 Cr ₹448 Cr ₹441 Cr +17.5%
Operating Profit ₹-66 Cr ₹-5 Cr ₹6 Cr +93.2%
OPM % -17.36% -1.01% 1.32% +94.2%
NPM % -35.33% -18.06% -15.11% +48.9%
Other Income ₹6 Cr ₹5 Cr ₹5 Cr -10.0%
Depreciation ₹44 Cr ₹45 Cr ₹45 Cr +2.8%
Interest ₹37 Cr ₹35 Cr ₹31 Cr -5.9%
EBIT ₹-110 Cr ₹-49 Cr ₹-39 Cr +55.0%
PBT ₹-141 Cr ₹-81 Cr ₹-67 Cr +42.5%
Tax ₹-7 Cr ₹-0 Cr ₹-0 Cr +97.9%
Net Profit ₹-135 Cr ₹-81 Cr ₹-67 Cr +39.9%
EPS ₹-65.24 ₹-38.34 ₹-29.89 +41.2%
Material Cost ₹97 Cr ₹212 Cr ₹229 Cr +118.8%
Employee Cost ₹32 Cr ₹47 Cr ₹48 Cr +48.9%
Extraordinary Items — ₹-2 Cr ₹-2 Cr —

🏛️ Balance Sheet (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Equity Capital 20202022 +10.0%
Reserves 400350215368 +71.2%
Borrowings 341494555449 -19.1%
Other Liabilities 21911292103 +12.0%
Total Liabilities 979975881942 +6.9%
Fixed Assets 318386499478 -4.2%
CWIP 127165210 -100.0%
Investments 0000 —
Other Assets 534424361463 +28.3%
Total Assets 979975881942 +6.9%

💧 Cash Flow (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity 7510-8-81 -912.5%
Cash from Investing Activity -113-135-15-4 +73.3%
Cash from Financing Activity 381252494 +291.7%
Net Cash Flow -0009 —
Free Cash Flow -42-125-24-86 -258.3%
CFO/OP 104%-211%20%1,768% +8740.0%

➗ Ratios (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Debtor Days 90135141202 +43.3%
Inventory Days 268224196169 -13.8%
Days Payable 161102100107 +7.0%
Cash Conversion Cycle 197256237263 +11.0%
Working Capital Days -17-1-26-56 -115.4%
ROCE % 8%-4%-13%-5% +61.5%

👥 Shareholding (latest 5 periods)

Metric Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 % Chg
Promoters 70.87%72.42%71.97%71.97%71.96% -0.0%
FIIs 0.02%0.00%0.04%0.03%0.01% -66.7%
DIIs 4.26%4.01%3.17%3.33%3.33% +0.0%
Public 24.84%23.57%24.82%24.67%24.69% +0.1%
No. of Shareholders 18,54918,27622,29321,04119,889 -5.5%

⚖️ Peer comparison

Industry: Pesticides / Agrochemicals - Indian · 19 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 SHARDACROP Sharda Cropchem ₹725.00 6,541 10.4 5,357 626 19.5% 11.7% 21.9% 123.7% 9.0% -38.4%
2 DHANUKA Dhanuka Agritech ₹961.85 4,288 16.4 1,978 265 19.6% 13.4% -24.5% -36.2% -7.9% -27.3%
3 RALLIS Rallis India ₹198.12 3,853 — — — — — 7.2% -28.4% — —
4 NACLIND NACL Industries ₹136.70 3,202 279.0 1,519 12 7.0% 0.8% 28.3% 105.0% -14.5% 59.8%
5 BHAGCHEM Bhagiradha Chemicals ₹244.25 3,167 115.2 607 28 13.0% 4.5% 21.7% 31.1% 57.6% 235.0%
6 BHARATRAS Bharat Rasayan ₹1,157.40 1,924 13.4 1,203 143 14.6% 11.9% 5.9% 3.3% -10.4% -6.1%
7 INSECTICID Insecticides (India) ₹608.95 1,772 14.2 2,060 125 10.1% 6.1% 7.0% -1.2% -11.5% -24.5%
8 IPL India Pesticides ₹134.99 1,555 14.4 1,033 108 15.9% 10.5% 27.5% 44.4% -8.5% -34.8%
9 ASTEC Astec LifeSciences ₹696.90 1,553 — 441 -67 1.3% -15.1% 17.5% 39.9% -8.3% 43.4%
10 MOL Meghmani Organics ₹57.90 1,472 22.9 2,103 64 9.9% 3.1% 4.5% 371.1% -11.5% 280.0%
11 PUNJABCHEM Punjab Chemicals ₹1,037.20 1,272 19.4 1,058 65 11.8% 6.2% 14.4% 64.3% 8.7% 7.0%
12 EXCELINDUS Excel Industries ₹966.80 1,215 17.0 1,079 71 10.2% 6.6% 11.9% -12.0% -5.1% -12.7%
13 DHARMAJ Dharmaj Crop ₹269.40 910 15.1 1,155 60 9.3% 5.2% 22.5% 91.4% 4.6% 16.8%
14 BESTAGRO Best Agrolife ₹18.99 674 22.6 1,272 30 10.4% 2.3% -30.7% -87.1% 4.0% 103.2%
15 HERANBA Heranba Industries ₹167.20 669 — 1,525 -77 5.7% -5.0% 13.1% -3549.1% -15.3% 11.2%
16 SHIVALIK Shivalik Rasayan ₹350.80 562 38.3 375 20 12.3% 5.2% 18.0% -12.0% 7.9% 59.5%
17 SIKKO Sikko Industries ₹5.85 256 41.9 65 6 12.0% 9.4% 2.3% 109.7% -2.3% 43.4%
18 CLSL Crop Life ₹48.35 83 12.6 207 7 8.2% 3.4% — — -7.4% 33.3%
19 ARISTO Aristo Bio-Tech ₹89.15 61 8.5 363 7 4.4% 1.9% — — 2.9% —
❓ Frequently asked questions
What was Astec LifeSciences Limited's revenue in Q1 FY27?
Astec LifeSciences Limited reported revenue of ₹84 crore for the quarter ended June 2026 (Q1 FY27), down 8.3% from ₹91 crore in the same quarter last year, and down 47.3% sequentially over the March 2026 quarter.
What was Astec LifeSciences Limited's net profit in Q1 FY27?
The company reported a net loss of ₹19 crore, against a net loss of ₹33 crore in the same quarter last year. Earnings per share (EPS) came in at ₹-8.40.
What is ASTEC's market capitalisation and P/E ratio?
At the current price of ₹710.45, ASTEC has a market capitalisation of ₹1,583 crore.
Who owns Astec LifeSciences Limited? (shareholding pattern)
As of Jun 2026, promoters held 71.96%, foreign institutional investors (FIIs) 0.01%, domestic institutional investors (DIIs) 3.33%, public shareholders 24.69% of Astec LifeSciences Limited.
TTM ends 2026-06-30. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI